The previous biochemical evidence had suggested that glutaric aciduria type I1 (GA 11) is due to deficient dehydrogenation o f . multiple shortchain acyl coenzyme A' s (CoA's), but the precise biochemical mechanism underlying this disease was unknown. We investigated substrate oxidation and in vitm activities of isovaleryl CoA-and butyryl CoA dehydrogenases as well as that of electrontransferring flavoprotein (ETF) in cultured skin fibroblasts from a patient with GA 11. GA I1 cells have a markedly decreased ability to oxidize 9 , and 9% of control values, respectively). Mitochondria1 isovaleryl CoA-and butyryl CoA dehydrogenase activities in GA I1 cells were determined using a tritium release assay with (2J-'HI acyl-CoA's as substrates. When an artificial electron acceptor, phenazine methosulfate (PMS) was not added in the assay media, these activities were 108 and 113% of controls, respectively. This represents the normal abilities of the dehydrogenases in GA I1 cells to bind the substrate and to catalyze tritium exchange between the bound substrate and solvent. When PMS was added to the assay mixture, these activities were 88 and 7096 of control values, respectively, indicating that these enzymes can both dehydrogenate their substrates normally and then transfer electrons to an acceptor (PMS).
ETF activity in mitochondria1 sonic supernatants from GA I1 cells, as assessed by a newly devised method, was 159% of control values. These observations suggest that the acyl CoA dehydrogenases themselves and ETF are not defective in GA 11. Therefore, the deficiency of another common gene product necessary for the function of all the affected acyl CoA dehydrogenases must be sought to explain the etiology of GA 11.
Speculation
Inasmuch as the data resented in this Dawr and those available in the literature suggestmthat deficiencies'of'the cofactors involved in shortchain fattv acid metabolism (flavin adenine dinucleoside. coenzyme A, and-carnitine) are a~s b unlikely in CA 11, othe; possibilities must be investigated. A unique iron-sulfur flavoprotein (electron-transferring flavoprotein dehydrogenase) has been isolated from beef heart mitochondria that appears to catalyze electron transfer from the reduced electron-transferring flavoprotein to coenzyme Q. Experiments are in progress to determine if this protein is present and catalytically active in glutaric aciduria type 11 fibroblasts.
Glutaric aciduria type I1 (GA 11) is an inborn error of metabolism characterized by hypoglycemia, metabolic acidosis, and a complex organic aciduria consisting of glutaric, ethylmalonic, isovaleric, a-methylbutyric, isobutyric, and hexanoic acids, as well as aliphatic dicarboxylic acids (5, 14). This disease was named GA I1 because glutarate was by far the predominant urinary metabolite in the original patient (14) and because it differed from glutaric aciduria (type I) in which only glutarate and its metabolites (glutaconate and 3-hydroxyglutarate) accumulate (6). GA I1 may be fatal in the neonatal period for infants affected with the severest form of the disorder, although a less severe form exists (5). In addition, a patient with ethylamalonic-adipic aciduria (EMA) has recently been described (12). In this disease, urinary metabolites are most often the same as those found in GA I1 except conspicuously low or absent excretion of glutarate. It has been demonstrated that the in vitro oxidation of "C-labeled glutaric acid, leucine, isoleucine, and valine by intact GA I1 fibroblasts was depressed (14). These results, coupled with the metabolite analyses in vivo, led to the hypothesis that dehydrogenation of multiple acyl coenzyme A's (CoA's) is deficient in this disorder ( Fig. 1) (14) . A similar pattern of metabolic blockade has also been observed in EMA fibroblasts (12). Because some of the short-chain acyl CoA's accumulated in GA I1 and EMA are known to be dehydrogenated by separate acyl CoA dehydrogenases (3, 8, 13, 16) , deficiency of another protein whose activity is essential to the function of all the involved dehydrogenases has been postulated as the mechanism underlying these two diseases (12, 14) . It is not known at present whether GA I1 and EMA result from allelic mutations of the same gene or if they are due to mutations in two different genes.
In an attempt to elucidate the biochemical basis of GA 11, we have investigated the oxidation of "C-labeled butyrate, lysine, leucine, and succinate by intact skin fibroblasts from the original patient with GA 11. In addition, we have assayed two enzymes, isovaleryl CoA and butyryl CoA dehydrogenases, as well as electron-transferring flavoprotein (ETF) (Fig. 2 ) in mitochondria isolated from GA I1 fibroblasts. This investigation was carried out with two new assay methods recently developed in our laboratory. These are the tritibm release assay fbr isovaieryl CoA and buty$ CoA dehydrogenases (15, 16) and a dye reduction assay for ETF.
MATERIALS AND METHODS
[2,3-3H]Isovaleric acid (10 mCi/mmole) and [2,3-3H]butyric acid (10 mCi/mmole) were synthesized by New England Nuclear, Boston, MA. Coenzyme A esters of the free acids were synthesized by the mixed anhydride method in our laboratory (23). The tritiated acyl CoA's were found to be 89 to 98% pure as analyzed by paper chromatography using ethano1:O.l M potassium acetate buffer (pH 4.5) mixture (1:l) as a developing solvent. Pure pig liver general acyl CoA dehydrogenase was a gift from Dr. Carole L. Hall, Georgia Institute of Technology, Atlanta, GA. Fibroblasts were cultured from skin biopsies of one patient with GA I1 and six normal individuals. The patient with GA I1 (14) was reported previously. Cells were grown in Eagle's minimal essential medium, supplemented with IWO fetal calf serum, glutamine, and nones- Mitochondria1 acyl CoA dehydrogenase activities were determined in duplicate using the tritium release assays which we have recently described (15, 16) . Total volume of the reaction mixture was 100 pl. The final concentrations of all reagents were as follows: Napi, 10 mM, pH 7.5: phenazine methosulfate (PMS), 18.8 mM: [2,3-'Hlacyl CoA, 100 pM. Sonic mitochondrial supernatants (25 to 50 pg protein per assay) were the enzyme source. Mitochondria were isolated from human fibroblasts by the method previously described (16) and were sonicated into 200 p1 NaPi, 12.5 mM, pH 7.5, using a Branson sonifier with a small tip and centrifuged at 40,000 x g for 30 min. After incubation at 37OC for 15 min, the reaction was stopped by addition of 5 pl of 0.5% iodine in 0.5 M HC1:75% ethanol; a 90 p1 aliquot of the resulting mixture was passed over a 0.5-ml column of AG-I anion exchange resin [acetate form (Bio-Rad)] and packed in a pasteur pipette, and the column washed with 1 ml deionized water. The tritium in the eluate was then quantiated by liquid scintillation. Dehydrogenase activities were also determined in the absence of phenazine methosulfate.
Mitochondria1 ETF was assayed by a modification of the dye reduction method which has been used for the acyl CoA dehydrogenases (9). The basic principle of this assay is that a vast excess of pure pig liver general acyl CoA dehydrogenase (GAD) and octanoyl CoA is added to an assay mixture which contains dichlorophenol indophenol (DCIP) as a terminal electron acceptor but omits the obligatory electron transfer agent (ETF or PMS). In this system, ETF activity in the fibroblast mitochondrial sonicate is rate limiting for electron transfer from GAD to DCIP (9). The total volume of assay mix was 0.625 ml. The final concentrations of all reagents were as follows: GAD, 4.6 pg/assay; octanoyl CoA, 40 pM; Nap,, 10 mM, pH 7.5; DCIP, 0.002%. The rates of dye reduction were calculated using the absorbance change in the interval from the second to fourth min after addition of substrate.
RESULTS
Przyrembel et al. (14) have demonstrated that oxidation of I4C-labeled substrates, including valine, leucine, isoleucine, glutarate, a-ketoisovderate, and a-ketoisocaproate by GA I1 fibroblasts was depressed but that pyruvate oxidation was normal. However, the degree of deficiency of these activities was somewhat obscured by their use of universally labeled substrates. The assay of glutaryl CoA oxidation in tissue homogenates from another patient with GA I1 has yielded confusing results; this activity was markedly deficient in liver and kidney from this patient, but was normal in fibroblasts (7).
First, we have extended the study of substrate oxidation using [l-14C]butyrate and specifically labeled leucine and lysine as substrates. The ability of GA I1 cells to oxidize [I-14C]butyrate, [2-14C]lysine, and [2-14C]leucine was 3, 9, and 9% of control values, respectively (Table 1) ; oxidation of [1,4-14C]succinate by GA I1 cells was unimpaired, suggesting that cell viability was normal ( Table 1 ). These findings indicate that the metabolic block in GA I1 is expressed in cultured fibroblasts and that mitochondrial electron transport from succinate to molecular oxygen is intact in GA I1 cells (Fig. 2) .
The activities of two acyl CoA dehydrogenases, isovaleryl CoA and butyryl CoA, were determined using the tritium release assay both in the presence and absence of PMS (1 5, 16). When assayed in the absence of PMS, tritium is released from the enzyme-bound [2,3-3H]acyl CoA's by exchange of protons with the assay medium ("exchange") and net oxidation of the substrate does not occur (4, 15). The amount of tritium released by exchange is not dependent on the presence of electron acceptor (15), but it is catalyzed by the dehydrogenase alone. The exchange activities for isovaleryl CoA and butyryl CoA of mitochondrial sonicates from GA I1 cells were 108 and 113% of control values, respectively (Table 2) . When assayed in the presence of PMS, the amounts of tritium released f r o i [2,3-3~]isovaleryl CoA and [2,3-3H]butyryl CoA by mitochondrial sonicates from both GA I1 and normal cells increased 35 and 460%, respectively, over those released by the exchange activities. Under such conditions, isovaleryl CoA and butyryl CoA dehydrogenase activities in GA I1 fibroblast mitochondria were 88 and 70%, respectively, of control values as shown in Table 2 .
These results suggest that the ability of the enzymes to bind the substrate (exchange) and the ability to abstract hydrogens from the substrate and transfer them to an electron acceptor (PMS) (true dehydrogenation) are not impaired significantly in G A 11.
Because ETF catalyzes the first reaction in the transfer of electrons from the reduced acyl CoA dehydrogenases to the respiratory chain in vivo (Fig. 2) , we assayed for ETF activity in GA I1 fibroblast mitochondria using a modification of the traditional dye reduction assay for the acyl CoA dehydrogenases as described in "Materials and Methods." In this assay system, a vast excess of octanoyl CoA and pure pig liver general acyl CoA dehydrogenase (GAD) was added as the source of reduced acyl CoA dehydrogenase, and DCIP was used as the terminal electron acceptor. Sonic supernatants from GA I1 fibroblast mitochondria were used as the source of ETF. Reduction of DCIP by reduced GAD will only occur if ETF is present and thus provides an effective assay for ETF. The amount of ETF is rate limiting under these conditions (9). Utilizing this method, in vitro mitochondrial ETF activity in GA I1 fibroblasts was higher than controls on two separate occasions, averaging 159% of control values ( Table 3 ), suggesting that ETF activity is not deficient in GA 11.
DISCUSSION
The studies presented above demonstrate that fibroblasts from a patient with GA I1 are severely deficient in their ability to oxidize I4C-labeled butyrate, leucine, and lysine. These cells were derived from an infant who died at 70 hr of age with hypoglycemia and metabolic acidosis (14) . Biochemical analysis of this patient's urine revealed massive excretion of glutaric, ethylmalonic, isovaleric, isobutyric, a-methylbutyric, and hexanoic acids, as well as dicarboxylic acids with 6, 8, and 10 carbons. Several related metabolites, isovaleryl-and hexanolylglycine, have recently been identified in the urine of an adult patient with GA I1 (5). These compounds are formed via the conjugation of the appropriate acyl CoA with glycine catalyzed by glycine N-acylase, a mitochondrial Mean of two experiments rt difference from the mean. 
' Assayed on two occasions. Numbers in parentheses, number of determinations.
enzyme; free carboxylic acids represent very poor substrates for this enzyme (2, 20) . It has also been shown that ethylmalonic acid is formed by carboxylation of butyryl CoA in mitochondria (21) when oxidation of butyryl CoA is inhibited (I). Thus, the pattern of metabolite accumulation, coupled with cell oxidation studies, suggests that in GA I1 and EMA the metabolism of multiple substrates is blocked at the step of acyl CoA dehydrogenation ( Fig. 1) (5, 12, 14) . Because many of the acyl CoA dehydrogenase activities deficient in GA 11, including those for butyryl-, isovaleryl-, and glutaryl CoA, are presumably regulated by different genes (3, 8, 9, 13, 16) , we must postulate a deficiency of a common gene product whose activity is essential to the function of all the affected dehydrogenases. Acyl CoA dehydrogenation in vivo is a complicated reaction which requires enzymes and proteins other than the dehydrogenases alone (Fig. 2) . Thus, pertinent possibilities for the etiology of GA I1 include deficiency of ca~itine-dependent mitochondrial transport of acyl CoA's (22), of cofactors and coenzymes [CoA or flavin adenine dinucleoside (FAD)], of a protein component or subunit common to all the acyl CoA dehydrogenases, or of proteins required for electron transport from the reduced acyl CoA dehydrogenases to coenzyme Q in the electron transport chain: ETF or iron-sulfur flavoprotein (ETF dehydrogenase) (Fig. 2) (9, 18, 19) . Carinitine deficiency as the cause of GA I1 is excluded because the pattern of metabolite accumulation in GA I1 is distinctly different from that observed in patients with systemic carnitine deficiency who do not excrete ethylmalonic and glutaric acids and acylglycines (I I). The accumulation of urinary bind substrate and to catalyze tritium exchange from substrate to solvent in the absence of PMS (exchange activity) and to transfer electrons to PMS (or "true dehydrogenase" activity) are not altered in GA I1 fibroblasts. Thus, it appears that a primary deficiency of the dehydrogenases is not the etiology of this disorder. This finding also excludes the possibility of a defective protein component or subunit common to all the acyl CoA dehydrogenases as the mechanism underlying GA 11. This result is also consistent with the evidence that all three straight chain acyl CoA dehydrogenases (butyryl CoA-, general acyl CoA-and long-chain acyl CoA dehydrogenases) are tetramers of identical subunits (a4) (9). These data are in sharp contrast to our findings in isovaleric acidemia fibroblasts; we have recently shown, using the tritium release assay with PMS, that isovaleryl CoA dehydrogenase activity is markedly decreased (13% of normal controls) in five isovaleiic acidemia cell lines, whereas butyryl CoA dehydrogenase activity is preserved at normal levels (16). Both isovaleryl CoA and butyryl CoA dehydrogenase activities were consistently lower (approximately 50% of controls, respectively) in EMA cells than in GA I1 cells (17).
Normal oxidation of '4C-succinate by GA I1 fibroblasts implies that succinic dehydrogenase, a FAD-requiring enzyme, is not deficient in these cells and is evidence against a defect in the synthesis of FAD (Table 1 ). In addition, there is some preliminary data suggesting that incorporation of I4C-labeled riboflavin into flavin-containing cofactors is normal in GA I1 (7). Normal succinate catabolism also suggests that the mitochondrial electron transport chain is functionally normal from coenzyme Q to cytochromes a and as (Fig. 2) (10) . In summary, deficiencies of a common dehydrogenase subunit, or of FAD, CoA, or carnitine biosynthesis can be excluded as the etiology of GA I1 from the evidence presented here and elsewhere.
Thus, the currently available evidence is consistent with the metabolic defect in GA I1 being in electron transport from the
